Dr. Amy Nance, M.D.
What this data tells you about Dr. Nance
Dr. Amy Nance is a hematology specialist in Gainesville, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Nance performed 135,758 Medicare services across 2,959 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nance received a total of $3,024 from 50 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nance is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 131863 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 98,940 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 9,490 | $1 | $5 |
| Paclitaxel chemotherapy injection | 6,114 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 5,770 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 3,180 | $18 | $51 |
| Iron infusion (Monoferric) | 2,500 | $16 | $57 |
| Complete blood count (CBC) with differential | 1,652 | $8 | $29 |
| Dexamethasone injection (steroid) | 1,567 | $0 | $3 |
| Blood draw (venipuncture) | 1,536 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 880 | $1 | $28 |
| Office visit, established patient (30-39 min) | 605 | $93 | $339 |
| Office visit, established patient, complex (40-54 min) | 407 | $132 | $474 |
| Drug injection, under skin or into muscle | 322 | $10 | $69 |
| Office visit, established patient (20-29 min) | 313 | $64 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 304 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 281 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 224 | $48 | $189 |
| Injection of additional new drug or substance into vein | 222 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 166 | $22 | $84 |
| Injection, zoledronic acid, 1 mg | 164 | $7 | $69 |
| Administration of additional new drug or substance into vein, 1 hour or less | 156 | $48 | $178 |
| Injection, carboplatin, 50 mg | 148 | $2 | $41 |
| Injection of drug or substance into vein | 90 | $27 | $156 |
| Infusion into a vein for hydration, each additional hour | 88 | $10 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 76 | $1 | $3 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 73 | $17 | $59 |
| Automated urinalysis | 71 | $2 | $8 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 70 | $1 | $6 |
| Infusion, normal saline solution , 1000 cc | 64 | $2 | $7 |
| Administration of chemotherapy into vein, each additional hour | 59 | $22 | $79 |
| Red blood count, automated test | 56 | $4 | $10 |
| Infusion into a vein for hydration, 31-60 minutes | 55 | $25 | $156 |
| Initial hospital admission, high complexity | 42 | $128 | $556 |
| New patient office visit, complex (60-74 min) | 32 | $162 | $585 |
| Hospital follow-up visit, high complexity | 23 | $94 | $285 |
| New patient office visit (45-59 min) | 18 | $123 | $453 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nance is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nance experienced with iron infusion (feraheme)?
Does Dr. Nance receive payments from pharmaceutical companies?
How do Dr. Nance's costs compare to other hematologists in Gainesville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology